Meropenem Dosing in Adults
For adults with normal renal function, administer meropenem 1 gram IV every 8 hours for severe infections including septic shock and deep-tissue infections, given as a 3-hour extended infusion rather than standard 30-minute infusion to optimize pharmacokinetic/pharmacodynamic targets 1.
Standard Dosing by Infection Type
For adults with creatinine clearance >50 mL/min:
- Complicated intra-abdominal infections: 1 gram IV every 8 hours 1
- Complicated skin/soft tissue infections: 500 mg IV every 8 hours, BUT increase to 1 gram every 8 hours if Pseudomonas aeruginosa suspected 1
- Septic shock: 1 gram IV every 8 hours minimum 2
The FDA label permits both 15-30 minute infusions and 3-5 minute bolus dosing for 1 gram doses 1. However, extended infusions of 3 hours are strongly preferred in critically ill patients based on pharmacokinetic optimization principles 3, 4, 5.
Dosing in Septic Shock and Severe Infections
The Surviving Sepsis Campaign guidelines emphasize pharmacokinetically optimized dosing strategies in septic patients 3. Extended or continuous infusions increase the time above MIC (T>MIC), which is critical for β-lactam efficacy 3.
For septic shock with suspected resistant organisms (MIC 4-8 mg/L):
- Consider 2 grams IV every 8 hours as 3-hour extended infusion 6, 7
- Alternative: 1 gram every 6 hours as extended infusion 5
Recent evidence demonstrates that standard 1 gram every 8 hours fails to achieve adequate exposure (fT>4×MIC) in 33-39% of septic patients, particularly against organisms with MIC ≥4 mg/L 5. A loading dose of 500 mg followed by 1500 mg every 8 hours as 3-hour infusion achieves better target attainment 5.
Renal Function Adjustments
Dosing must be reduced in renal impairment 1:
| Creatinine Clearance | Dose Adjustment |
|---|---|
| >50 mL/min | Standard dose (500 mg or 1 g q8h) |
| 26-50 mL/min | Standard dose every 12 hours |
| 10-25 mL/min | Half dose every 12 hours |
| <10 mL/min | Half dose every 24 hours |
Calculate creatinine clearance using Cockcroft-Gault equation 1:
- Males: CrCl = [Weight(kg) × (140-age)] / [72 × SCr(mg/dL)]
- Females: 0.85 × male value
Critical caveat: The FDA label provides inadequate guidance for hemodialysis patients 1. Dose after dialysis sessions when possible.
Augmented Renal Clearance (ARC)
In critically ill patients with CrCl 140-200 mL/min, standard dosing is insufficient 6. These patients require:
- 2 grams every 8 hours as 4-6 hour infusion for MIC 2-4 mg/L 6
- Continuous infusion may be necessary for MIC >4 mg/L 6
ARC occurs commonly in septic patients during early resuscitation phases and leads to subtherapeutic meropenem levels 3, 6. Current eGFR methods correlate poorly with actual meropenem clearance in critically ill children and likely adults 8.
Therapeutic Drug Monitoring Targets
When TDM is available, target:
- Trough (Cmin) ≥5.3 mg/L for general infections 9
- Cmin ≥7.3 mg/L for bloodstream infections 9
- Cmin ≥8 mg/L for bacterial clearance 9
- Peak (Cmax) ≥39.4 mg/L (≥49.1 mg/L for bacteremia) 9
However, avoid excessive concentrations: trough >64 mg/L for meropenem increases neurotoxicity risk, particularly in renal dysfunction 4. When fCmin/MIC ratio exceeds 8, neurological deterioration occurs in approximately 50-67% of ICU patients 4.
Practical Dosing Algorithm
Assess renal function using Cockcroft-Gault (not eGFR equations which correlate poorly) 8
For CrCl >50 mL/min:
- Start 1 gram IV every 8 hours as 3-hour infusion
- Increase to 2 grams every 8 hours if septic shock + suspected MIC >2 mg/L
For CrCl 26-50 mL/min:
- 1 gram every 12 hours
For CrCl 10-25 mL/min:
- 500 mg every 12 hours
For CrCl <10 mL/min:
- 500 mg every 24 hours
Reassess daily: Renal function in critically ill patients fluctuates dramatically 8, 9. Adjust doses accordingly.
Key Pitfalls to Avoid
- Do not use standard 30-minute infusions in septic shock—extended infusions (≥2-3 hours) achieve significantly better clinical outcomes 7, 5, 9
- Do not assume normal dosing in early sepsis—ARC is common and causes treatment failure 6
- Do not rely on eGFR equations—use Cockcroft-Gault for dosing decisions 1, 8
- Do not continue standard doses for P. aeruginosa or Acinetobacter—these require intensified regimens or alternative therapy 6
- Do not combine with probenecid—inhibits renal excretion and is not recommended 1